MARY GROSS: Open Payments
NPI 1952646861 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $141 · 2025 $252
Food & beverage: $174Education: $78
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $120 |
| Janssen Biotech, Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Astellas Pharma US Inc | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $21 |
Products named: RYBREVANT, Fabhalta, Padcev, CALQUENCE, KEYTRUDA, DATROWAY, TAGRISSO.
Industry payments across MD — which companies pay providers there.
